US Stock MarketDetailed Quotes
CTXR Citius Pharmaceuticals
- 3.6400
- +0.0900+2.54%
Close Dec 4 16:00 ET
- 3.4600
- -0.1800-4.95%
Post 20:02 ET
28.13MMarket Cap-606P/E (TTM)
3.7500High3.1500Low173.03KVolume3.4800Open3.5500Pre Close611.78KTurnover2.27%Turnover RatioLossP/E (Static)7.73MShares26.750052wk High0.33P/B27.77MFloat Cap2.550052wk Low--Dividend TTM7.63MShs Float750.0000Historical High--Div YieldTTM16.90%Amplitude2.5500Historical Low3.5350Avg Price1Lot Size
Citius Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q4)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 22.63%10.63M | 2.67%10.97M | 28.84%9.34M | 10.25%36.73M | 34.11%10.12M | -2.74%8.67M | 40.77%10.69M | -21.70%7.25M | 41.58%33.32M | 45.09%7.55M |
| Selling and administrative expenses | 60.38%7.87M | 23.59%7.36M | 76.61%6.72M | 39.92%21.91M | 96.14%7.24M | 21.82%4.91M | 43.98%5.96M | 0.08%3.8M | 38.69%15.66M | 26.93%3.69M |
| -General and administrative expense | 60.38%7.87M | 23.59%7.36M | 76.61%6.72M | 39.92%21.91M | 96.14%7.24M | 21.82%4.91M | 43.98%5.96M | 0.08%3.8M | 38.69%15.66M | 26.93%3.69M |
| Research and development costs | -26.58%2.76M | -23.71%3.61M | -23.90%2.62M | -16.06%14.82M | -25.27%2.88M | -22.98%3.76M | 36.92%4.73M | -36.87%3.45M | 44.24%17.66M | 68.13%3.86M |
| Operating profit | -22.63%-10.63M | -2.67%-10.97M | -28.84%-9.34M | -10.25%-36.73M | -34.11%-10.12M | 2.74%-8.67M | -40.77%-10.69M | 21.70%-7.25M | -41.58%-33.32M | -45.09%-7.55M |
| Net non-operating interest income expense | -39.18%204.84K | -39.92%182.21K | 18.22%253.64K | 369.14%1.18M | 140.91%324.81K | 535.19%336.78K | 925.58%303.28K | 531.36%214.55K | 0.16%251.4K | 78.34%134.83K |
| Non-operating interest income | -39.18%204.84K | -39.92%182.21K | 18.22%253.64K | 369.14%1.18M | 140.91%324.81K | 535.19%336.78K | 925.58%303.28K | 531.36%214.55K | -3.98%251.4K | 78.34%134.83K |
| Other net income (expense) | 2.39M | 3.59M | 0 | 3.59M | ||||||
| Other non- operating income (expenses) | ---- | --2.39M | ---- | --3.59M | --0 | ---- | ---- | --3.59M | ---- | ---- |
| Income before tax | -25.12%-10.43M | 19.09%-8.4M | -163.42%-9.09M | 3.32%-31.97M | -32.17%-9.8M | 5.96%-8.34M | -37.31%-10.38M | 62.61%-3.45M | -43.42%-33.06M | -49.46%-7.41M |
| Income tax | 0.00%144K | 0.00%144K | 0.00%144K | 0.00%576K | -75.00%144K | 144K | 144K | 144K | 576K | 576K |
| Net income | -24.70%-10.57M | 18.83%-8.54M | -156.88%-9.23M | 3.26%-32.54M | -24.44%-9.94M | 4.34%-8.48M | -39.21%-10.53M | 61.05%-3.59M | -45.92%-33.64M | -61.07%-7.99M |
| Net income continuous Operations | -24.70%-10.57M | 18.83%-8.54M | -156.88%-9.23M | 3.26%-32.54M | -24.44%-9.94M | 4.34%-8.48M | -39.21%-10.53M | 61.05%-3.59M | -45.92%-33.64M | -61.07%-7.99M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -24.70%-10.57M | 18.83%-8.54M | -156.88%-9.23M | 3.26%-32.54M | -24.44%-9.94M | 4.34%-8.48M | -39.21%-10.53M | 61.05%-3.59M | -45.92%-33.64M | -61.07%-7.99M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 321.56K | 1.15M | 1.15M | 0 | 0 | |||||
| Net income attributable to common stockholders | -28.49%-10.89M | 18.83%-8.54M | -156.88%-9.23M | -0.16%-33.69M | -38.85%-11.1M | 4.34%-8.48M | -39.21%-10.53M | 61.05%-3.59M | -37.28%-33.64M | -61.07%-7.99M |
| Basic earnings per share | 0.00%-1.5 | 28.57%-1.25 | -200.00%-1.5 | 4.35%-5.5 | -40.00%-1.75 | 0.00%-1.5 | -40.00%-1.75 | 66.67%-0.5 | 0.00%-5.75 | -66.67%-1.25 |
| Diluted earnings per share | 0.00%-1.5 | 28.57%-1.25 | -200.00%-1.5 | 4.35%-5.5 | -40.00%-1.75 | 0.00%-1.5 | -40.00%-1.75 | 66.67%-0.5 | 0.00%-5.75 | -66.67%-1.25 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
